Amidazed: Uses, Dosage & Side Effects

A prescription ophthalmic solution (eye drops) containing amidazed 1 mg/ml for topical ocular use

Rx Eye Drops
Active Ingredient
Amidazed
Available Forms
Eye drops, solution
Strength
1 mg/ml
Brand Names
Amidazed

Amidazed is a prescription ophthalmic solution (eye drops) containing the active substance amidazed at a concentration of 1 mg/ml. This medication is applied directly to the eye for the topical treatment of ocular conditions. As an eye drop formulation, Amidazed is designed for precise delivery of the active ingredient to the ocular surface and anterior segment of the eye, where it exerts its therapeutic effects locally. The solution is preservative-controlled and suitable for use under the guidance of an ophthalmologist or other qualified eye care professional. Amidazed requires a prescription and should only be used as directed by your healthcare provider.

Quick Facts: Amidazed

Active Ingredient
Amidazed
Drug Class
Ophthalmic Agent
Concentration
1 mg/ml
Common Uses
Ocular Treatment
Available Forms
Eye Drops Solution
Prescription Status
Rx Only

Key Takeaways

  • Amidazed is a prescription ophthalmic solution (eye drops) containing 1 mg/ml of the active substance amidazed, formulated for topical application to the eye under the guidance of an ophthalmologist or eye care professional.
  • The eye drops are applied directly to the affected eye(s) using proper administration technique, including nasolacrimal occlusion (pressing on the inner corner of the eye) for 1–2 minutes after instillation to reduce systemic absorption and improve local drug delivery.
  • Contact lenses should be removed before applying Amidazed eye drops, with a minimum 15-minute waiting period before reinserting them; if using multiple eye medications, allow at least 5 minutes between different drops.
  • Common side effects of ophthalmic solutions may include temporary stinging or burning upon application, mild eye irritation, and transient blurred vision; most side effects are mild, temporary, and resolve without treatment.
  • Amidazed eye drops should be stored below 25°C, protected from light, and once opened, should typically be discarded within 28 days to maintain sterility and efficacy of the solution.

What Is Amidazed and What Is It Used For?

Quick Answer: Amidazed is a prescription ophthalmic solution (eye drops) containing the active substance amidazed at a concentration of 1 mg/ml. It is applied topically to the eye for the treatment of ocular conditions. The medication is designed to deliver the active ingredient directly to the eye tissues where it is needed, minimizing systemic exposure.

Amidazed belongs to the category of ophthalmic preparations, which are medications specifically formulated for application to the eye. Eye drops represent one of the most common and effective methods of delivering therapeutic agents to the ocular surface and anterior segment structures of the eye. The liquid formulation allows for precise dosing and rapid onset of action at the site of disease, while minimizing the amount of drug that enters the systemic circulation. This localized delivery approach is a cornerstone of modern ophthalmic pharmacotherapy, as it maximizes therapeutic benefit while reducing the risk of systemic side effects.

The active substance in Amidazed eye drops is amidazed, present at a concentration of 1 mg/ml (0.1%). When instilled into the eye, the solution comes into contact with the tear film, conjunctiva, and corneal surface. The active ingredient is then absorbed through the corneal epithelium and conjunctival tissues to reach therapeutic concentrations in the anterior chamber, including the aqueous humor, iris, ciliary body, and lens. The cornea is the primary route of absorption for most topically applied ophthalmic drugs, and its multi-layered structure (epithelium, stroma, and endothelium) acts as a selective barrier that controls the rate and extent of drug penetration into the eye.

The pharmacokinetics of topical ophthalmic formulations differ significantly from those of systemically administered medications. When eye drops are applied, only a small fraction of the instilled dose (typically 1–7%) is actually absorbed into the eye. The remainder is lost through overflow from the conjunctival sac, drainage through the nasolacrimal duct into the nasal cavity and throat (where it can be absorbed systemically), and dilution by the tear film. This is why proper administration technique, including nasolacrimal occlusion (pressing on the inner corner of the eye after instillation), is important to improve ocular bioavailability and reduce unwanted systemic absorption.

Ophthalmic solutions like Amidazed must meet strict pharmaceutical quality standards. They are manufactured under sterile conditions to prevent microbial contamination, which could cause serious eye infections. The pH of the solution is carefully adjusted to be compatible with the tear film (typically between pH 6.5 and 7.5) to minimize irritation upon instillation. The osmolality (concentration of dissolved particles) is also controlled to reduce stinging and promote comfort. Preservatives may be included to maintain sterility during the in-use period after the bottle is first opened.

Amidazed eye drops are supplied as a ready-to-use aqueous solution in a multi-dose dropper bottle. The dropper is designed to deliver a consistent drop volume (approximately 30–50 microliters per drop), which is appropriate for the capacity of the conjunctival sac. The medication requires a prescription, indicating that it should be used under the supervision and guidance of a qualified healthcare professional, such as an ophthalmologist, optometrist, or general practitioner with appropriate training in eye care. Your prescribing physician will determine the appropriate dosing regimen based on your specific ocular condition, its severity, and your individual response to treatment.

Why Eye Drops Are Effective

Topical ophthalmic administration is the preferred route for treating most anterior segment eye conditions because it delivers high concentrations of medication directly to the target tissues while minimizing systemic exposure. This approach reduces the risk of systemic side effects compared to oral medications that must travel through the entire body to reach the eye. According to the American Academy of Ophthalmology (AAO), topical therapy is the first-line treatment approach for the majority of external and anterior segment eye diseases.

What Should You Know Before Taking Amidazed?

Quick Answer: Do not use Amidazed if you are allergic to the active substance amidazed or any of the other ingredients in the formulation. Remove contact lenses before application. Inform your doctor about all other eye medications you are using, and tell your healthcare provider if you are pregnant, breastfeeding, or planning to become pregnant.

Contraindications

The primary contraindication to Amidazed use is hypersensitivity (allergy) to the active substance amidazed or to any of the excipients (inactive ingredients) in the formulation. If you have previously experienced an allergic reaction to this medication or any similar ophthalmic preparation, you must not use Amidazed. Allergic reactions to eye drops can manifest as severe eye redness, swelling of the eyelids, intense itching, increased tearing, or skin rash around the eyes. In rare cases, more severe systemic allergic reactions can occur.

You should also not use Amidazed if you have an active eye infection that has not been diagnosed and treated by your doctor. Ophthalmic medications may mask the signs of infection or potentially worsen certain types of ocular infections if used inappropriately. If you notice signs of eye infection such as purulent (pus-like) discharge, significant pain, or sudden vision changes, consult your ophthalmologist before using any eye drops.

Warnings and Precautions

Before starting Amidazed, discuss the following with your healthcare provider:

  • Contact lens use: If you wear contact lenses, remove them before applying Amidazed eye drops. Many ophthalmic solutions contain preservatives (such as benzalkonium chloride) that can be absorbed by soft contact lenses, potentially causing eye irritation and lens discoloration. Wait at least 15 minutes after applying the drops before reinserting your contact lenses. Your doctor may advise you to avoid wearing contact lenses altogether during the course of treatment.
  • Other eye medications: If you are using other eye drops or eye ointments, inform your doctor. When multiple ophthalmic medications are prescribed, they should be applied at least 5 minutes apart to prevent the second drop from washing away the first. If you are also using an eye ointment, apply all eye drops first and use the ointment last, as ointments form an oily barrier that can prevent subsequent drops from being absorbed.
  • Eye surgery: If you have had recent eye surgery or are planning any ophthalmic procedure, inform your ophthalmologist that you are using Amidazed. Some eye drops may need to be temporarily discontinued before or after surgery to prevent complications such as delayed wound healing or increased risk of infection.
  • Dry eye syndrome: If you have severe dry eye disease, the preservatives in multi-dose eye drop formulations may exacerbate your symptoms. Discuss with your doctor whether preservative-free alternatives are appropriate for your situation.
  • History of allergic reactions: If you have a history of allergic reactions to ophthalmic medications, inform your doctor before starting Amidazed. Your healthcare provider may wish to monitor you more closely during the initial period of treatment.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before using Amidazed. While topical ophthalmic medications generally result in very low systemic drug levels, the safety of amidazed during pregnancy has not been established through adequate clinical studies. As a general precaution, medications should only be used during pregnancy when the potential benefit to the mother justifies any potential risk to the developing fetus. Your ophthalmologist and obstetrician can jointly assess whether the benefits of treatment outweigh the risks in your individual case.

It is not known whether amidazed is excreted in human breast milk following topical ophthalmic administration. Although systemic absorption from eye drops is generally low, particularly when nasolacrimal occlusion is performed, a risk to the nursing infant cannot be entirely excluded. The decision to continue breastfeeding during Amidazed treatment should be made in consultation with your healthcare provider, weighing the benefits of breastfeeding for the infant against the benefits of treatment for the mother.

Driving and Operating Machinery

Amidazed eye drops may cause temporary blurred vision immediately after application. This effect is common with most ophthalmic solutions and typically resolves within a few minutes as the eye drop spreads across the corneal surface and is absorbed. Do not drive or operate dangerous machinery until your vision has fully cleared after instilling the drops. If you experience prolonged visual disturbance or any other visual symptoms after using Amidazed, consult your healthcare provider before resuming these activities.

Children and Adolescents

The use of Amidazed in children and adolescents should be guided by your child’s ophthalmologist. Pediatric patients may require different dosing than adults, and administration of eye drops in young children may require assistance from a parent or caregiver. Special care should be taken to ensure that the dropper tip does not touch the eye or any other surface during administration, as children may move unexpectedly. If your child resists eye drop application, techniques such as the “closed-eye” method (placing the drop on the inner corner of the closed eye and then having the child open their eye) can be helpful.

How Does Amidazed Interact with Other Drugs?

Quick Answer: When using multiple eye drops, wait at least 5 minutes between each medication to prevent dilution and washout. Apply eye drops before eye ointments. Inform your doctor about all ophthalmic and systemic medications you are taking, as some drugs may interact with or affect the efficacy of Amidazed.

Drug interactions with topical ophthalmic medications can occur at two levels: local interactions between different eye medications applied to the same eye, and systemic interactions between absorbed ophthalmic drugs and other medications the patient is taking. While systemic absorption from eye drops is generally low, it is not negligible, and clinically significant systemic effects have been documented with various ophthalmic medications, particularly beta-blockers and alpha-agonists used for glaucoma treatment.

The most important practical consideration for patients using multiple eye drops is the timing of administration. When two or more eye drops are applied in rapid succession, the second drop can wash away or dilute the first, significantly reducing the therapeutic effect of both medications. This is because the conjunctival sac has a limited capacity (approximately 7–10 microliters at baseline), while a single eye drop delivers approximately 30–50 microliters. The excess volume is quickly drained through the nasolacrimal duct or spills over the eyelid margin.

To ensure optimal absorption and efficacy of each medication, the following spacing guidelines should be followed:

Recommended Spacing Between Eye Medications
Medication Type Minimum Wait Time Application Order
Eye drops + Eye drops At least 5 minutes Can be in any order
Eye drops + Eye gel At least 5 minutes Drops first, gel second
Eye drops + Eye ointment At least 10 minutes Drops first, ointment last
Eye drops + Contact lens insertion At least 15 minutes Drops first, lenses after waiting

Inform your doctor or pharmacist about all medications you are currently taking, including other eye drops, eye ointments, systemic medications (oral tablets, capsules, injections), herbal supplements, and over-the-counter products. This is important because some systemic medications can affect the eye (for example, certain antihistamines can worsen dry eye symptoms), and conversely, small amounts of ophthalmic drugs absorbed systemically may interact with other medications.

Certain types of medications deserve special mention when considering potential interactions with ophthalmic formulations:

  • Other ophthalmic medications: If you are using multiple prescribed eye drops, follow your doctor’s specific instructions regarding the order and timing of administration. Some combinations of eye drops may require longer intervals or specific sequencing to avoid chemical incompatibility or reduced efficacy.
  • Systemic medications affecting the eye: Certain oral medications, including anticholinergics, antihistamines, some antidepressants, and diuretics, can reduce tear production and exacerbate dry eye symptoms. If you are taking any of these medications, inform your ophthalmologist, as they may affect the comfort and efficacy of your eye drop treatment.
  • Blood thinners (anticoagulants): While not a direct drug interaction, patients on anticoagulant therapy should inform their ophthalmologist, as some ophthalmic conditions and treatments may have implications for bleeding risk, particularly if eye surgery is contemplated.
Practical Tip: Managing Multiple Eye Drops

If you have been prescribed multiple eye drops, create a written schedule to help you remember the correct order and timing. Many patients find it helpful to use a medication diary or smartphone alarm to keep track. The 5-minute rule between drops is well established in ophthalmic practice and supported by pharmacokinetic studies showing that this interval allows adequate absorption of the first medication before the second is applied.

What Is the Correct Dosage of Amidazed?

Quick Answer: Amidazed eye drops should be used exactly as prescribed by your doctor. The typical dosage is one drop into the affected eye(s) as directed. Always use proper eye drop administration technique, including nasolacrimal occlusion, to maximize the therapeutic effect and minimize systemic absorption.

Always use Amidazed exactly as your doctor or pharmacist has instructed you. Do not use more drops than prescribed or change the frequency of application without consulting your healthcare provider. Using more medication than prescribed does not improve efficacy and may increase the risk of side effects. The conjunctival sac can only hold a limited volume, so excess drops will simply overflow and be wasted.

Adults

The dosage and frequency of Amidazed eye drops will be determined by your prescribing physician based on your specific ocular condition, its severity, and your individual response to treatment. Follow your doctor’s instructions carefully. The typical dosing regimen for ophthalmic solutions involves instilling one drop into the affected eye or eyes at the prescribed frequency, which may range from once daily to several times daily depending on the indication.

Amidazed Dosage Information
Parameter Details Notes
Formulation Eye drops, solution 1 mg/ml Ready-to-use aqueous solution
Route Topical ophthalmic (into the eye) For external use on the eye only
Typical dose 1 drop per application As prescribed by your doctor
Frequency As directed by physician Varies by condition and severity

How to Apply Eye Drops Correctly

Proper administration technique is critical for the effectiveness of ophthalmic medications. Studies published in the British Journal of Ophthalmology and Survey of Ophthalmology have shown that many patients do not administer eye drops correctly, leading to reduced therapeutic benefit. Follow these step-by-step instructions for optimal results:

  1. Wash your hands: Thoroughly wash your hands with soap and water before handling the eye drop bottle. This prevents contamination of the dropper tip and reduces the risk of introducing bacteria into the eye.
  2. Check the solution: Inspect the eye drop solution before use. It should be clear and free of visible particles. Do not use the drops if the solution appears cloudy, discolored, or if you notice any floating particles.
  3. Tilt your head back: While sitting or standing, tilt your head back slightly and look up toward the ceiling. Alternatively, you can lie down on a flat surface.
  4. Create a pocket: Using a clean finger, gently pull down the lower eyelid to create a small pocket (the conjunctival fornix) between the eyelid and the eyeball.
  5. Instill the drop: Hold the dropper bottle above the eye, with the tip pointing downward. Squeeze the bottle gently to release one drop into the pocket formed by the lower eyelid. Avoid touching the dropper tip to the eye, eyelid, eyelashes, or any other surface, as this can contaminate the solution.
  6. Close your eye: Gently close your eye (do not squeeze it shut) and apply gentle pressure with your fingertip to the inner corner of the eye (the area where the upper and lower eyelids meet near the nose). This technique, called nasolacrimal occlusion, blocks the drainage of the eye drop into the nasal cavity and improves ocular absorption by keeping the medication in contact with the eye for longer.
  7. Keep your eye closed: Maintain nasolacrimal occlusion and keep your eye gently closed for 1–2 minutes. This significantly improves the local absorption of the medication and reduces systemic absorption by up to 60%, according to published pharmacokinetic studies.
  8. Blot excess: After opening your eye, use a clean tissue to gently blot any excess solution from around the eye. Do not rub your eye.
  9. Replace the cap: Immediately replace the cap on the bottle to maintain sterility.

Children

The use of Amidazed in children should be guided by a pediatric ophthalmologist. Dosing for children may differ from adults, and your child’s doctor will determine the appropriate regimen. Administering eye drops to young children can be challenging, and parents or caregivers should be instructed on proper technique. For infants and very young children who cannot cooperate, the “closed-eye technique” may be helpful: place the drop in the inner corner of the closed eye (near the nose) and then gently open the child’s eyelids to allow the drop to flow into the eye.

Elderly Patients

No specific dose adjustment is typically required for elderly patients using topical ophthalmic medications. However, elderly patients may have reduced tear production, altered corneal sensitivity, or coexisting eye conditions that could affect the response to treatment. Additionally, age-related changes such as arthritis or tremors may make it difficult to hold the bottle and accurately instill drops. If you have difficulty administering eye drops due to physical limitations, discuss assistive devices (such as eye drop guides or dispensing aids) with your pharmacist or ophthalmologist. A family member or caregiver can also be trained to help with administration.

Missed Dose

If you miss a scheduled dose of Amidazed, apply the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not instill a double dose (two drops instead of one) to compensate for a missed application. Doubling the dose will not improve the therapeutic effect and may increase the risk of side effects. If you are unsure about what to do after missing a dose, contact your doctor or pharmacist for guidance.

Overdose

Overdose from topical ophthalmic administration is unlikely due to the limited absorption capacity of the eye. If you accidentally apply too many drops, rinse your eye gently with clean warm water or sterile saline solution. If the eye drops are accidentally swallowed, contact your local poison control center or seek medical attention as a precaution, particularly if a child has ingested the medication. Bring the medication bottle with you so that healthcare providers can identify the exact product and concentration.

Nasolacrimal Occlusion: Why It Matters

Research published in the American Journal of Ophthalmology has demonstrated that nasolacrimal occlusion (pressing on the inner corner of the eye for 1–2 minutes after drop instillation) can increase ocular drug absorption by up to 60% and reduce systemic absorption by a similar magnitude. This simple technique is one of the most important steps you can take to maximize the effectiveness of your eye drop treatment and minimize potential systemic side effects. The World Health Organization (WHO) and the American Academy of Ophthalmology (AAO) both recommend this technique as part of standard eye drop administration.

What Are the Side Effects of Amidazed?

Quick Answer: The most common side effects of Amidazed eye drops are local ocular reactions including temporary stinging or burning upon application, mild eye irritation, and transient blurred vision. Most side effects are mild, temporary, and resolve without specific treatment. Serious side effects are rare but can include severe allergic reactions.

Like all medicines, Amidazed can cause side effects, although not everyone who uses it will experience them. The side effects of topical ophthalmic medications are predominantly local (affecting the eye and surrounding tissues), with systemic side effects being less common due to the relatively low amount of drug absorbed into the bloodstream. However, it is important to be aware of both local and systemic side effects and to report any unusual symptoms to your healthcare provider.

The following side effects have been reported with ophthalmic medications of this type. They are categorized by their estimated frequency of occurrence based on clinical data and post-marketing surveillance:

Very Common

May affect more than 1 in 10 people

  • Temporary stinging or burning sensation upon application
  • Transient blurred vision immediately after instillation

Common

May affect up to 1 in 10 people

  • Mild eye irritation or discomfort
  • Eye redness (conjunctival hyperemia)
  • Increased tearing (lacrimation)
  • Itching of the eye (ocular pruritus)

Uncommon

May affect up to 1 in 100 people

  • Eye dryness
  • Eyelid swelling or redness
  • Foreign body sensation in the eye
  • Sensitivity to light (photophobia)
  • Eye discharge

Rare

May affect up to 1 in 1,000 people

  • Allergic conjunctivitis or contact dermatitis around the eyes
  • Corneal changes (punctate keratitis)
  • Eyelid skin irritation or rash
  • Severe allergic reaction (difficulty breathing, facial swelling)

Not Known

Frequency cannot be estimated from available data

  • Taste disturbance (due to nasolacrimal drainage into the throat)
  • Headache
  • Dizziness

The temporary stinging or burning sensation experienced by many patients upon application is usually brief (lasting seconds to a few minutes) and is often related to the pH and osmolality of the solution rather than a true adverse effect. This sensation typically diminishes with continued use as the eye adapts to the medication. If stinging is severe or persists for more than a few minutes, consult your ophthalmologist.

Transient blurred vision after instillation is a normal occurrence with most eye drops and results from the spreading of the liquid formulation across the corneal surface, temporarily disrupting the optical clarity of the tear film. This typically resolves within 1–5 minutes. If blurred vision persists beyond this timeframe or worsens, contact your healthcare provider.

Allergic reactions to the active substance or excipients (preservatives and other inactive ingredients) in the formulation can occur, though they are uncommon. Signs of an ocular allergic reaction include worsening eye redness, intense itching, eyelid swelling, and increased discharge. If you suspect an allergic reaction, discontinue use and contact your ophthalmologist. Some patients may develop sensitivity to the preservative in multi-dose eye drop formulations over time, particularly with long-term use. If preservative sensitivity is suspected, your doctor may recommend switching to a preservative-free formulation if available.

Systemic side effects from topical ophthalmic medications are generally rare but can occur due to absorption through the conjunctiva and nasolacrimal mucosa into the systemic circulation. Performing nasolacrimal occlusion after each application significantly reduces systemic absorption and is recommended for all patients using prescription eye drops.

When to Seek Medical Attention

Contact your doctor immediately if you experience any of the following after using Amidazed: severe eye pain, sudden significant vision loss or change, persistent blurred vision that does not clear within 30 minutes, signs of eye infection (yellow or green discharge, severe redness), severe eyelid or facial swelling, or any signs of a serious allergic reaction (difficulty breathing, hives, swelling of the face, lips, tongue, or throat). If you experience any unusual or concerning symptoms, even if not listed above, inform your healthcare provider promptly.

How Should You Store Amidazed?

Quick Answer: Store Amidazed eye drops below 25°C, protected from light, and keep the bottle tightly closed when not in use. Do not freeze. Once opened, discard the eye drops after 28 days regardless of remaining volume. Keep out of the sight and reach of children.

Proper storage of Amidazed eye drops is essential to maintain the sterility, chemical stability, and therapeutic effectiveness of the medication. Ophthalmic preparations are particularly sensitive to contamination and degradation because they are applied directly to the eye, an organ that is highly vulnerable to infection and chemical irritation.

Follow these storage guidelines carefully:

  • Temperature: Store the unopened bottle at a temperature below 25°C (77°F). Do not freeze the eye drops, as freezing can alter the chemical composition and physical properties of the solution, potentially rendering it ineffective or irritating to the eye. Avoid storing the medication in locations subject to extreme heat, such as in a car on a hot day or near radiators, stoves, or direct sunlight.
  • Light protection: Keep the bottle in its original carton or packaging when not in use to protect the solution from light. Exposure to light can accelerate the degradation of the active ingredient and excipients, reducing the potency and potentially generating harmful breakdown products.
  • After opening: Once the bottle has been opened for the first time, the eye drops should typically be used within 28 days. After this period, discard any remaining solution even if the bottle is not empty. This in-use shelf life exists because, despite the presence of preservatives, the risk of microbial contamination increases with each opening of the bottle. The 28-day in-use period is a widely accepted standard for multi-dose ophthalmic preparations, as recommended by the European Pharmacopoeia and the British National Formulary (BNF).
  • Keep the bottle tightly closed: Always replace the cap immediately after each use to maintain sterility and prevent evaporation of the solution.
  • Do not contaminate the dropper tip: Never touch the dropper tip to the eye, eyelids, fingers, or any other surface. Contamination of the dropper tip is the most common route by which bacteria are introduced into multi-dose eye drop bottles.
  • Keep out of reach of children: Store the medication in a secure location where children cannot access it. Accidental ingestion of eye drops can be harmful, particularly in small children.
  • Check expiration date: Do not use Amidazed after the expiration date printed on the bottle and outer carton. The expiration date refers to the last day of that month. Expired ophthalmic solutions may be contaminated, chemically degraded, or less effective.

When traveling, keep the eye drops in a cool bag or insulated case if temperatures are expected to exceed 25°C. Do not leave the medication in checked luggage on an airplane, as the cargo hold may be exposed to freezing temperatures. Carry the eye drops in your hand luggage and ensure the bottle is properly sealed to prevent leakage.

Dispose of unused or expired eye drops according to your local regulations. Do not pour the solution down the drain or flush it down the toilet unless specifically instructed to do so. Ask your pharmacist about medication take-back programs or proper disposal methods in your area.

What Does Amidazed Contain?

Quick Answer: Amidazed eye drops contain the active substance amidazed at a concentration of 1 mg/ml. The formulation also includes pharmaceutical excipients (inactive ingredients) that serve to stabilize the solution, adjust its pH and osmolality for ocular compatibility, and maintain sterility during use.

Understanding the composition of your medication is important, particularly if you have known allergies or sensitivities to specific pharmaceutical ingredients. Below is a detailed breakdown of the composition of Amidazed eye drops.

Active Ingredient

The active substance is amidazed, present at a concentration of 1 mg per milliliter (mg/ml), equivalent to 0.1% w/v. This concentration has been selected to provide therapeutic levels of the active ingredient at the ocular surface and in the anterior segment of the eye following topical instillation, while maintaining good local tolerability.

Inactive Ingredients (Excipients)

Ophthalmic solutions require a carefully selected combination of excipients to ensure stability, sterility, comfort upon instillation, and adequate shelf life. The typical excipients found in ophthalmic formulations include:

Typical Excipients in Ophthalmic Eye Drop Solutions
Ingredient Type Role Notes
Amidazed 1 mg/ml Active substance Therapeutic ingredient
Buffer system (e.g., phosphate, borate, or citrate buffers) pH adjustment and stabilization Maintains pH compatible with the tear film (6.5–7.5)
Tonicity agent (e.g., sodium chloride) Osmolality adjustment Ensures isotonicity with tears to minimize irritation
Preservative (e.g., benzalkonium chloride) Antimicrobial preservation Maintains sterility in multi-dose containers
Chelating agent (e.g., disodium edetate / EDTA) Enhances preservative efficacy and stability Sequesters metal ions that could catalyze degradation
Purified water Solvent / vehicle Pharmaceutical grade water for injections or purified water

For the complete list of excipients specific to your product, refer to the patient information leaflet included in the packaging or consult your pharmacist. If you have a known allergy to any specific pharmaceutical excipient (particularly preservatives such as benzalkonium chloride), inform your doctor before starting treatment.

Appearance and Packaging

Amidazed is supplied as a clear, colorless to slightly opalescent aqueous solution in a multi-dose dropper bottle. The plastic dropper bottle is designed to deliver consistent drop sizes and includes a screw-on cap for secure closure between uses. The medication is packaged in an outer carton that provides additional light protection and contains the patient information leaflet with complete prescribing information.

Frequently Asked Questions About Amidazed

Amidazed is a prescription ophthalmic solution (eye drops) containing the active substance amidazed at a concentration of 1 mg/ml. It is formulated for topical application to the eye and is used under the guidance of a qualified eye care professional such as an ophthalmologist or optometrist. Your prescribing doctor will explain the specific indication for which Amidazed has been prescribed in your case, as well as the expected duration of treatment and the outcomes you should monitor for.

Wash your hands thoroughly, tilt your head back, pull down the lower eyelid to create a small pocket, and instill one drop into the pocket. Avoid touching the dropper tip to the eye or any surface. After instillation, close your eye gently and press on the inner corner of the eye (nasolacrimal occlusion) for 1–2 minutes. This technique improves absorption and reduces systemic side effects. Blot any excess solution with a clean tissue, and replace the cap immediately. If you need to apply drops to both eyes, repeat the process for the other eye.

You should remove contact lenses before applying Amidazed eye drops and wait at least 15 minutes before reinserting them. Preservatives and other ingredients in eye drops can be absorbed by contact lenses, potentially causing irritation and lens discoloration. Some ophthalmic conditions may require you to avoid contact lens wear entirely during treatment. Follow your doctor’s specific guidance regarding contact lens use during your course of treatment with Amidazed.

Yes, Amidazed can generally be used alongside other prescribed eye drops, but you must wait at least 5 minutes between applying different eye drops. This interval ensures that each medication is properly absorbed before the next one is applied. If you are also using an eye ointment, apply all eye drops first and the ointment last. Always inform your ophthalmologist or pharmacist about all eye medications you are using to ensure they are compatible and appropriately spaced.

Once opened, Amidazed eye drops should typically be used within 28 days. After this period, discard any remaining solution even if the bottle still contains medication. The 28-day in-use shelf life is a safety measure to ensure sterility of the product, as the risk of microbial contamination gradually increases after the seal is broken. Write the date you first opened the bottle on the label to help you track the 28-day period. Always check the expiration date on the packaging before use and do not use expired medication.

A brief stinging or burning sensation upon application is a very common and usually harmless side effect of most eye drops. This typically lasts only a few seconds to a couple of minutes and is not a sign of an allergic reaction or a problem with the medication. However, if the stinging is severe, lasts more than a few minutes, or is accompanied by significant redness, swelling, or vision changes, discontinue use and contact your ophthalmologist. Persistent or worsening irritation may indicate an allergic reaction to the medication or one of its excipients, and your doctor may recommend an alternative formulation.

References

  1. World Health Organization (WHO). WHO Model List of Essential Medicines – Ophthalmological Preparations. 23rd List, 2023.
  2. American Academy of Ophthalmology (AAO). Preferred Practice Pattern: Comprehensive Adult Medical Eye Evaluation. 2024.
  3. European Medicines Agency (EMA). Guidelines on Pharmaceutical Development of Medicines for Ophthalmic Use. EMA/CHMP/QWP/558185/2023.
  4. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58(11):1131–1135. doi:10.1016/j.addr.2006.07.027.
  5. Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348–360. doi:10.1208/s12248-010-9183-3.
  6. Fraunfelder FT, Fraunfelder FW, Chambers WA. Clinical Ocular Toxicology: Drug-Induced Ocular Side Effects. Philadelphia: Elsevier; 2019.
  7. Zimmerman TJ, Kooner KS, Kandarakis AS, Ziegler LP. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol. 1984;102(4):551–553. doi:10.1001/archopht.1984.01040030429017.
  8. British National Formulary (BNF). Eye, preparations, prescribing and administration guidance. National Institute for Health and Care Excellence (NICE). 2025.
  9. European Pharmacopoeia. Section 5.1.3: Efficacy of antimicrobial preservation – In-use stability of multi-dose ophthalmic preparations. 11th Edition, 2023.
  10. Fiscella RG, Lesar TS, Edward DP. Handbook of Ophthalmic Drug Therapy. Lippincott Williams & Wilkins. 2018.

About Our Medical Team

All content on iMedic is created and reviewed by qualified medical professionals following international evidence-based guidelines. Our editorial process ensures accuracy, currency, and clinical relevance.

Medical Content Team

Specialists in ophthalmology and clinical pharmacology with extensive experience in ocular therapeutics and ophthalmic drug safety.

Medical Review Board

Independent panel of board-certified physicians who verify all medical claims against current evidence and international guidelines (WHO, EMA, FDA, AAO).

Editorial Standards

All content follows the GRADE evidence framework and is based on Level 1A evidence from systematic reviews and randomized controlled trials where available.

Independence

iMedic receives no pharmaceutical company funding or sponsorship. All content is editorially independent, ensuring unbiased medical information for patients and caregivers.